| Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade JJ Ishizuka, RT Manguso, CK Cheruiyot, K Bi, A Panda, A Iracheta-Vellve, ... Nature 565 (7737), 43-48, 2019 | 518 | 2019 |
| In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer J Dubrot, PP Du, SK Lane-Reticker, EA Kessler, AJ Muscato, A Mehta, ... Nature Immunology 23 (10), 1495-1506, 2022 | 84 | 2022 |
| In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinoma J Dubrot, SK Lane-Reticker, EA Kessler, A Ayer, G Mishra, CH Wolfe, ... Immunity 54 (3), 571-585. e6, 2021 | 65 | 2021 |
| Halfway to sustainability: Management lessons from community-based, marine no-take zones in the Mexican Caribbean A Ayer, S Fulton, JA Caamal-Madrigal, A Espinoza-Tenorio Marine Policy 93, 22-30, 2018 | 35 | 2018 |
| The future of heart procurement with donation after circulatory death: current practice and opportunities for advancement A Ayer, JN Schroder, S Casalinova, JW Doberne, BS Bryner, CB Patel, ... The Journal of Heart and Lung Transplantation 41 (10), 1385-1390, 2022 | 14 | 2022 |
| Improved outcomes in severe primary graft dysfunction after heart transplantation following donation after circulatory death compared with donation after brain death A Ayer, LK Truby, JN Schroder, S Casalinova, CL Green, MA Bishawi, ... Journal of Cardiac Failure 29 (1), 67-75, 2023 | 13 | 2023 |
| The impact of hearing loss and its treatment on health-related quality of life utility: A systematic review with meta-analysis ED Borre, K Kaalund, N Frisco, G Zhang, A Ayer, M Kelly-Hedrick, ... Journal of General Internal Medicine 38 (2), 456-479, 2023 | 11 | 2023 |
| Evidence gaps in economic analyses of hearing healthcare: a systematic review ED Borre, MM Diab, A Ayer, G Zhang, SD Emmett, DL Tucci, BS Wilson, ... EClinicalMedicine 35, 2021 | 11 | 2021 |
| Priorities for hearing loss prevention and estimates of global cause-specific burdens of hearing loss: a systematic rapid review K Prasad, ED Borre, LK Dillard, A Ayer, C Der, KE Bainbridge, ... The Lancet Global Health 12 (2), e217-e225, 2024 | 3 | 2024 |
| Variation among organ procurement organizations in experience and practice of heart donation after circulatory death A Ayer, BS Bryner, CB Patel, JN Schroder, CA Milano, MA Bishawi, ... JTCVS open 14, 185-187, 2023 | 1 | 2023 |
| Validation of the Decision model of the Burden of Hearing loss Across the Lifespan (DeciBHAL) in Chile, India, and Nigeria ED Borre, A Ayer, C Der, T Ibekwe, SD Emmett, S Dixit, M Shahid, ... Eclinicalmedicine 50, 2022 | 1 | 2022 |
| Evidence Gaps in Cost-Effectiveness Analyses of Hearing Health Care: A Systematic Review ED Borre, MM Diab, A Ayer, G Zhang, SD Emmett, DL Tucci, BS Wilson, ... 42nd Annual Meeting of the Society for Medical Decision Making, 2020 | 1 | 2020 |
| Lessons in building community support for no-take MPAs from the Mexican Caribbean A Ayer, S Fulton, J Caamal-Madrigal, A Espinoza-Tenorio, MC OCTO OCTO, 2018 | 1 | 2018 |
| Comparative Outcomes of Simultaneous Heart-Kidney Transplantation from DBD and DDC-NRP Donors MJ Kearns, A Ayer, E Silver, A Brubaker, C Weber, D Olaso, H Tran, ... The Journal of Heart and Lung Transplantation 43 (4), S265, 2024 | | 2024 |
| Outcomes in Donation After Circulatory Death Cardiac Transplantation Following Direct Procurement and Perfusion Compared with Normothermic Regional Perfusion MJ Kearns, A Ayer, A Birs, A Topik, E Adler, M Urey, V Pretorius The Journal of Heart and Lung Transplantation 43 (4), S122, 2024 | | 2024 |
| Improved Outcomes in Severe Primary Graft Dysfunction Following Heart Transplantation With Donation After Circulatory Death Compared to Donation After Brain Death A Ayer, L Truby, J Schroder, S Casalinova, C Green, M Bishawi, B Bryner, ... Circulation 146 (Suppl_1), A11945-A11945, 2022 | | 2022 |
| Abstract B10: Novel CRISPR/Cas9 vectors for in vivo tumor functional genomics J Dubrot, RT Manguso, SK Lane-Reticker, A Ayer, E Kessler, C Wolfe, ... Cancer Immunology Research 8 (3_Supplement), B10-B10, 2020 | | 2020 |
| Novel CRISPR/Cas9 vectors for in vivo tumor functional genomics. J Dubrot, RT Manguso, SK Lane-Reticker, A Ayer, E Kessler, C Wolfe, ... CANCER IMMUNOLOGY RESEARCH 8 (3), 90-90, 2020 | | 2020 |
